FDA also approved Thermo Fisher Scientific's (TMO) Oncomine Dx Target Test as a companion diagnostic for identifying patients with the tumor mutation.
FDA also approved Thermo Fisher Scientific's (TMO) Oncomine Dx Target Test as a companion diagnostic for identifying patients with the tumor mutation.